Loading company…
Stellaromics develops 3D in situ multi-omic analysis tools for biomedical research.
Stellaromics develops technology for optical analysis of multi-omic information in biological tissue. Its tools detect high-resolution 3D transcription patterns while preserving tissue structure, helping researchers map gene expression in thick samples. Founded in 2022 by Ye Fu and Christopher Kroeger, the company is based in Boston, US. In February 2025, it raised USD 80 million in Series B funding led by Catalyst Fund, with Standford University participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in